Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q2 2026 · 10-Q
Revenue$5.36K$5.36K−28.3% vs Q2 2025 Net Income-$1.50M-$1.50MN/M vs Q2 2025 EPS Diluted-$0.51-$0.51N/M vs Q2 2025 Operating Income-$1,498,147N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,342,364N/M Margins · derivedOperating margin-27950.5%−5493.0 pt vs Q2 2025
Net margin-28012.5%−5494.8 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 7, 2026 · 38 d after period end